These are now available on Ko-fi for $40 a piece!! They're off-base headshot designs of various dragons, so these lines will never be used again!
Support me on Ko-Fi!
seen from Spain

seen from Spain

seen from United States
seen from Türkiye
seen from United States
seen from Mexico
seen from Lithuania
seen from China
seen from United States

seen from United States

seen from United States

seen from United States
seen from Pakistan

seen from Syria

seen from United States
seen from United States
seen from China

seen from Türkiye

seen from United States
seen from United States
These are now available on Ko-fi for $40 a piece!! They're off-base headshot designs of various dragons, so these lines will never be used again!
Support me on Ko-Fi!
three off-base custom designs! the last one is an alcon, an original species ^^ relatively proud of all of these
The NY Times has become a lighting rod for attacking the drug industry. While the drug industry at time does need a good slap an editorial in today’s Times on the cost of Avastin vs. benefit takes on the wrong sponsors. More than 50 percent of cancer therapies are prescribed off-label, according to the National Association of Independent Review Organizations, which estimates that 20 percent of all drugs are used off-label. When the FDA asked for the label change it was patients and physicians who yelled the most, not Genentech